Systemic immune-inflammation index and other inflammatory parameters in patients receiving biological or targeted synthetic DMARDs for inflammatory rheumatic disease

Gezer H. H., Pehlivan O.

MARMARA MEDICAL JOURNAL, vol.35, no.3, pp.316-322, 2022 (ESCI, Scopus, TRDizin) identifier identifier

  • Publication Type: Article / Article
  • Volume: 35 Issue: 3
  • Publication Date: 2022
  • Doi Number: 10.5472/marumj.1186732
  • Journal Name: MARMARA MEDICAL JOURNAL
  • Journal Indexes: Emerging Sources Citation Index (ESCI), Scopus, Academic Search Premier, CINAHL, EMBASE, TR DİZİN (ULAKBİM)
  • Page Numbers: pp.316-322
  • Keywords: Inflammation, Systemic immune inflammation index, Biological treatment, TO-LYMPHOCYTE RATIO, MEAN PLATELET VOLUME, NEUTROPHIL, PSORIASIS, MARKERS
  • Marmara University Affiliated: No

Abstract

Objective: To investigate the short - and long-term dynamics in inflammation markers [systemic immune-inflammation index (SII), neutrophil/lymphocyte ratio (NLR), platelet/lymphocyte ratio (PLR), and lymphocyte/ monocyte ratio (LMR)] before and after biological disease-modifying antirheumatic drugs (bDMARD) or targeted synthetic DMARD (tsDMARD) treatment.